Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Oxytocin for Prevention of Post-partum Hemorrhage
NCT06968481Phase 2Not yet recruiting
- Sponsor
- Insud Pharma
- Start
- May 2026
- Primary completion
- Oct 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in postpartum hemorrhage (PPH), sponsored by Insud Pharma. Planned start May 2026; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06968481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06968481.